(Q37945288)

25 August 2017

title

Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy (English)

1 reference

25 August 2017

1 reference

Guan Jiang

1 reference

25 August 2017

Lei Zhang

1 reference

25 August 2017

Yong Xin

1 reference

25 August 2017

Dong-Sheng Pei

1 reference

25 August 2017

Zhi-Ping Wei

1 reference

25 August 2017

Yan-Qun Liu

1 reference

25 August 2017

Jun-Nian Zheng

1 reference

25 August 2017

publication date

13 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

285-292

1 reference

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

The development of MDA-7/IL-24 as a cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Current developments in adenovirus-based cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Armed replicating adenoviruses for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Targeting gene-virotherapy of cancer and its prosperity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Adenoviral vector-mediated gene transfer for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

IL-24: physiological and supraphysiological effects on normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A cancer terminator virus eradicates both primary and distant human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Double-regulated oncolytic adenovirus-mediated interleukin-24 overexpression exhibits potent antitumor activity on gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Control of Bcl-2 expression by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Angiogenesis in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Use of replicating oncolytic adenoviruses in combination therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Clinical trials with oncolytic adenovirus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Current issues and future directions of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.621447

10.3109/0284186X.2011.621447

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference